What caused OBSN.SW stock to drop intraday?

The intraday drop to CHF 0.0012 reflected heavy selling on thin liquidity. Volume spiked to 2,351,202 shares versus an average of 675,842. In micro-cap biotechs, size and limited bids can trigger steep intraday falls absent a clear fundamental trigger.

What is the Meyka AI grade for OBSN.SW stock?

Meyka AI rates OBSN.SW with a score out of 100: 62.41, Grade B, Suggestion: HOLD. The grade mixes sector comparison, financial growth, key metrics and forecast signals and is for informational purposes only.

What short-term price targets apply to OBSN.SW stock?

Scenario targets: conservative CHF 0.0025, base CHF 0.0050, optimistic CHF 0.0100. These reflect event-driven upside potential but acknowledge high volatility and liquidity risk.

Should I trade OBSN.SW stock on intraday moves?

Intraday trading is possible but risky: use small sizes and limit orders. The stock’s low quoted price and small market cap amplify slippage and execution risk, so strict risk controls are essential.

CH Stocks

OBSN.SW ObsEva S.A. (SIX) falls to CHF0.0012 on 2.35M volume 17 Feb 2026: monitor liquidity

ByDanny Kontos February 17, 2026February 17, 2026

ObsEva S.A. (OBSN.SW) hit CHF 0.0012 intraday on 17 Feb 2026 after a sharp sell-off, making it one of the most active names on the SIX today. The move came on 2,351,202 shares traded, roughly 3.48x the average volume, and pushed market participants to re-price risk in this small-cap Swiss biotech. This OBSN.SW stock note explains the drivers behind the drop, links pipeline and cash metrics to the price action, and flags short-term liquidity and catalyst points traders should watch on the intraday tape.